(Q37838426)

24 August 2017

1 reference

title

Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke (English)

1 reference

24 August 2017

0 references

0 references

Mira Katan

1

0 references

Mitchell S V Elkind

series ordinal

2

object named as

Mitchell S V Elkind

1 reference

24 August 2017

publication date

1 February 2011

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

225-239

1 reference

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Molecular biomarkers in stroke diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The potential role of carbon dioxide in the neuroimmunoendocrine changes following cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Social stress exacerbates stroke outcome by suppressing Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Gene expression profiling of blood for the prediction of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Identification of novel brain biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Modeling cerebral ischemia in neuroproteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Improving outcome after stroke: overcoming the translational roadblock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Interleukin-1 and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The science of stroke: mechanisms in search of treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The inflammatory response in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Dual role of tumor necrosis factor alpha in brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The pathophysiological role of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

IL-6: an early marker for outcome in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammatory biomarkers in blood of patients with acute brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammatory markers and in-hospital mortality in acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammation in acute ischemic stroke and its relevance to stroke critical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Associations of proinflammatory cytokines with the risk of recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Tumor necrosis factor-alpha expression in ischemic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Tumor necrosis factor receptor levels are associated with carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Circulating endothelial cells in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Raised plasma oxidised LDL in acute cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Clinical application of blood biomarkers in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Markers of inflammation and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Hyperfibrinogenemia and functional outcome from acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Is D-dimer helpful in evaluating stroke patients? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Progression in lacunar stroke is related to elevated acute phase parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasma thrombosis markers following cerebral infarction in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Predictive variables for mortality after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

C-reactive protein and coronary heart disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

C-reactive protein in atherosclerosis: A causal factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Mechanisms of C-reactive protein-induced blood-brain barrier disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Editorial: why inhibition of lipoprotein-associated phospholipase A2 has the potential to improve patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Physiology and neurobiology of stress and adaptation: central role of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Neuroendocrinology of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Neuroanatomic correlates of stroke-related myocardial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Catecholamines, infection, and death in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Monocytes are major players in the prognosis and risk of infection after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasma catecholamines--analytical challenges and physiological limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Immunohistochemistry of atrial natriuretic peptide in brain infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Natriuretic peptides and mortality after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Endocrinology of the stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Hypercortisolism after stroke--partly cytokine-mediated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Glucocorticoids and immune function: unknown dimensions and new frontiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Urinary free cortisol excretion shortly after ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Serum-cortisol reflects severity and mortality in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Hypercortisolemia in acute stroke is related to the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The brain-heart connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Bioassay research methodology: measuring CRH in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Copeptin: a novel, independent prognostic marker in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Circadian secretion pattern of copeptin, the C-terminal vasopressin precursor fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Conversion of ischemic brain tissue into infarction increases with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

The real estate factor: quantifying the impact of infarct location on stroke severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: A critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Blood markers for the prognosis of ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

A comparison of goodness-of-fit tests for the logistic regression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Midregional Pro-Atrial Natriuretic Peptide and Outcome in Patients With Acute Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

Prognostic Value of Copeptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.200

21 January 2018

Identifiers

DOI

10.1586/ERN.10.200

1 reference

24 August 2017

1 reference